SPDR S&P Biotech ETF $XBI Position Trimmed by Strategic Financial Services Inc.

Strategic Financial Services Inc. decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 60.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,823 shares of the exchange traded fund’s stock after selling 17,913 shares during the quarter. Strategic Financial Services Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,871,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Compound Planning Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 0.7% in the 1st quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock worth $1,391,000 after acquiring an additional 75 shares during the last quarter. Dynamic Wealth Strategies LLC raised its position in shares of SPDR S&P Biotech ETF by 3.8% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after purchasing an additional 80 shares during the period. PeakShares LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 5.2% during the first quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock valued at $215,000 after purchasing an additional 84 shares during the last quarter. Commerce Bank lifted its holdings in shares of SPDR S&P Biotech ETF by 2.8% during the fourth quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock valued at $397,000 after purchasing an additional 90 shares during the last quarter. Finally, Moors & Cabot Inc. boosted its position in shares of SPDR S&P Biotech ETF by 3.8% in the 3rd quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock valued at $272,000 after purchasing an additional 100 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $163.81 on Monday. The business’s 50-day moving average price is $158.18 and its 200 day moving average price is $140.63. The stock has a market capitalization of $10.70 billion, a P/E ratio of 11.47 and a beta of 0.84. SPDR S&P Biotech ETF has a 1-year low of $92.64 and a 1-year high of $169.89.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.